Rachel Capone, MSHS
Advertisement
Rachel Capone, MSHS, is a regulatory affairs manager, Syner-G BioPharma Group.
Articles by Rachel Capone, MSHS
Advertisement
Latest Updated Articles
Unlocking the Benefits of FDA’s Orphan Drug DesignationPublished: August 22nd 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal
2
Network Disconnection, Not Lesion Volume, Drives MS Cognition
3
Sexual Dysfunction From Cancer Is Widespread—and Many Don’t Know That Before Treatment, Data Show
4
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
5
